S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML

Detalles Bibliográficos
Autores principales: Gyurkocza, Boglarka, Seropian, Stuart, Choe, Hannah, Litzow, Mark, Abboud, Camille, Koshy, Nebu, Stiff, Patrick, Tomlinson, Benjamin, Abhyankar, Sunil, Foran, James M, Hari, Parameswaran, Chen, George, Al-Kadhimi, Zaid, Kebriaei, Partow, Sabloff, Mitchell, Orozco, Johnnie, Jamieson, Katarzyna, Silverman, Margarida, Van Besien, Koen, Schuster, Michael, Law, Arjun, Abedin, Sameem, Larkin, Karilyn, Rowley, Scott, Munshi, Pashna, Cook, Rachel, Mayer, Sebastian, Levy, Moshe Yair, Lazarus, Hillard, Sandmaier, Brenda, Reddy, Vijay, Spross, Jennifer, Mcnamara, Kathleen, Haeuber, Elaina, Vusirikala, Madhuri, Nahar, Akash, Pagel, John, Giralt, Sergio, Desai, Avinash, Nath, Rajneesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428510/
http://dx.doi.org/10.1097/01.HS9.0000967904.29417.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428510/
http://dx.doi.org/10.1097/01.HS9.0000967904.29417.23

Ejemplares similares